Mourad Hamimed

4PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 17, 2026
Combined Docetaxel-Loaded Perfluorocarbon Nanodroplets with Ultrasound-Mediated Blood-Brain Barrier Disruption for Effective Glioblastoma Treatment in Mice Model.

|Nov 27, 2023
Killing a fly with a sledgehammer: Atezolizumab exposure in real-world lung cancer patients.

Sophie Marolleau, Alice Mogenet, Clara Boeri

|Jun 25, 2022
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysis.

Mourad Hamimed, Pierre Leblond, Aurélie Dumont

|Oct 28, 2021
Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade glioma.

Mourad Hamimed, Florence Gattacceca, Nicolas André

Pageof 1

Frequent Collaborators

2 joint publications

Nicolas André

2 joint publications

Caroline Solas

2 joint publications

Joseph Ciccolini

1 joint publications

Sophie Marolleau